CID 3013108

N-butyl-4-[4-[4-(n-butylcarbamimidoyl)phenyl]piperazin-1-yl]benzamidine

Structural Information

Molecular Formula
C26H38N6
SMILES
CCCCN=C(C1=CC=C(C=C1)N2CCN(CC2)C3=CC=C(C=C3)C(=NCCCC)N)N
InChI
InChI=1S/C26H38N6/c1-3-5-15-29-25(27)21-7-11-23(12-8-21)31-17-19-32(20-18-31)24-13-9-22(10-14-24)26(28)30-16-6-4-2/h7-14H,3-6,15-20H2,1-2H3,(H2,27,29)(H2,28,30)
InChIKey
MUJHQBQAGZJGTP-UHFFFAOYSA-N
Compound name
N'-butyl-4-[4-[4-(N'-butylcarbamimidoyl)phenyl]piperazin-1-yl]benzenecarboximidamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

2
References

1
Patents

434.3158 Da
Monoisotopic Mass

4.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 435.32308 211.3
[M+Na]+ 457.30502 211.2
[M-H]- 433.30852 217.7
[M+NH4]+ 452.34962 217.0
[M+K]+ 473.27896 205.2
[M+H-H2O]+ 417.31306 198.1
[M+HCOO]- 479.31400 230.2
[M+CH3COO]- 493.32965 246.2
[M+Na-2H]- 455.29047 209.6
[M]+ 434.31525 206.1
[M]- 434.31635 206.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe